8-KMaterial AgreementsFinancial EventsExhibits & Filings

DEXCOM INC 8-K Report, Material Agreement (Mar 24, 2006)

Filed March 24, 2006For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed an 8-K on March 24, 2006, to report a material definitive agreement. The company entered into a Loan and Security Agreement with Square 1 Bank on March 20, 2006, for a credit facility of up to $5 million. This funding is intended to finance various equipment expenses. The loan carries an interest rate of the Square 1 prime rate plus 0.25% and matures in September 2009. This $5 million credit line represents a significant financing event for DexCom, suggesting the company is investing in its operational capacity and equipment. Investors should note the terms of the agreement, including the collateral provided (substantially all of the company's personal property) and the various covenants and limitations imposed on the company. These restrictions cover areas such as business operations, mergers, incurring additional debt, and dividend payments, which are typical for secured lending arrangements.

Key Highlights

  • 1DexCom secured a $5 million loan facility from Square 1 Bank on March 20, 2006.
  • 2The loan is designated to finance equipment expenses.
  • 3The facility matures on September 20, 2009.
  • 4Interest rate is set at the Square 1 prime rate plus 0.25%.
  • 5DexCom has pledged substantially all of its personal property as collateral.
  • 6The agreement includes several covenants restricting DexCom's business activities, such as limitations on mergers, additional indebtedness, and dividend payments.

Frequently Asked Questions

The primary purpose of the $5 million loan from Square 1 Bank is to finance various equipment expenses for DexCom, Inc.

The loan has a maturity date of September 20, 2009, and carries an interest rate of the Square 1 prime rate plus 0.25%. DexterCo has granted a security interest in substantially all of its personal property as collateral.

Yes, the loan agreement imposes several restrictions on DexCom, including limitations on transferring businesses, engaging in new business lines, relocating offices, merging, incurring additional debt (with exceptions), paying dividends, acquiring other companies, and entering into material affiliate transactions, among others.

As of the date of the filing of this Form 8-K (March 24, 2006), DexCom had not incurred any borrowings under the Loan Agreement.